{
      "brief_title": [
            "aripiprazole",
            "patient",
            "psychosis",
            "associate",
            "parkinson",
            "disease"
      ],
      "brief_summary": [
            "purpose",
            "clinical",
            "research",
            "study",
            "ass",
            "safety",
            "tolerability",
            "aripiprazole",
            "patient",
            "psychosis",
            "associate",
            "parkinson",
            "disease"
      ],
      "condition": [
            "psychosis"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "aripiprazole"
      ],
      "description": [
            "tablet",
            "oral",
            "daily",
            "6",
            "week"
      ],
      "arm_group_label": [],
      "other_name": [
            "abilify"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "primary",
            "diagnosis",
            "idiopathic",
            "parkinson",
            "disease",
            "psychosis",
            "relate",
            "parkinson",
            "disease",
            "exclusion",
            "criterion",
            "psychosis",
            "present",
            "prior",
            "diagnosis",
            "parkinson",
            "disease"
      ],
      "gender": [],
      "minimum_age": [
            "50",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00095810.xml"
}